DRUG PRODUCT MANUFACTURING SERVICES AGREEMENTDrug Product Manufacturing Services Agreement • November 9th, 2017 • Depomed Inc • Pharmaceutical preparations • New York
THIS DRUG PRODUCT MANUFACTURING SERVICES AGREEMENT (this “Agreement”) is effective as of June 6, 2017 (the “Effective Date”) by and between Halo Pharmaceutical, Inc., a Delaware corporation (“Halo”), and Depomed, Inc., a California corporation (“Client”).
DRUG PRODUCT MANUFACTURING SERVICES AGREEMENTDrug Product Manufacturing Services Agreement • November 13th, 2017 • New York
THIS DRUG PRODUCT MANUFACTURING SERVICES AGREEMENT (this “Agreement”) is effective as of ________ (the “Effective Date”) by and between ________ (“AAA”), and ________ (“Client”).
DRUG PRODUCT MANUFACTURING SERVICES AGREEMENTDrug Product Manufacturing Services Agreement • May 10th, 2017 • Egalet Corp • Pharmaceutical preparations • New Jersey
THIS DRUG PRODUCT MANUFACTURING SERVICES AGREEMENT (this “Agreement”) is effective as of February 28, 2017 (the “Effective Date”) by and between Halo Pharmaceutical, Inc., a Delaware corporation, having offices at 30 North Jefferson Road, Whippany, NJ 07981 (“Halo”), and Egalet Corporation, a Delaware corporation, having offices at 600 East Lee Road Suite 100 Wayne, PA 19087, Egalet, Ltd, a UK company having offices at 160 Queen Victoria Street London EC4V 4QQ and Egalet US Inc., having offices at 600 Lee Road, Wayne, PA 19087 (collectively known as “Client”).
